Streamlining the clinical trials management process in Spain could attract more international clinical trials to the country, providing economic benefits. Calculations estimated that streamlining activation procedures could increase the number of international clinical trials in Spain by 8% annually, attracting over 137 new trials in 3 years. This could generate 140 million euros in economic impact and create 452 new jobs, while also providing 8,000 patients early access to innovative treatments. Improving management processes could provide Spain a competitive advantage to participate in more global clinical research.
The future of healthcare is an exciting one. With innovations in genomics, healthcare data, advanced therapies and innovative technologies, our industry will continue to progress and provide hope to people so they can live longer, healthier and productive lives.
Mozambique has been working to improve its civil registration and vital statistics (CRVS) system. In 2007, the Ministry of Health started revising the mortality system by implementing an intra-hospital mortality register, training on death certification and ICD-10, and expanding to more sites. This triggered broader inter-sectoral efforts through a working group to expand registration to all deaths and review the entire CRVS system. The working group aims to strengthen death and birth registration and allow easier information sharing between sectors.
The value partnership between NHS, industry and other providersGS1 UK
This document summarizes a presentation given by Dr. Richard Greville on the value partnership between the NHS, pharmaceutical industry, and other healthcare providers in the UK. It discusses several challenges facing the NHS, including the important role of medicines, issues with medicines optimization, and the Pharmaceutical Price Regulation Scheme (PPRS). It outlines efforts through the PPRS and a medicines optimization program between NHS England and the industry group ABPI to improve patient outcomes and extract more value from healthcare spending. Specific initiatives discussed include implementing safety features like serialization and tamper evidence on medicines to protect the supply chain.
The document discusses antibiotic consumption data in UK hospitals. It notes that hospital inpatient antibiotic use increased 11.9% from 2010-2013 while other settings remained stable. There is significant regional variation in antibiotic use both within general practices and between hospitals. The document also examines different methods of dispensing antibiotics in hospitals and issues with using patient days vs. admissions as denominators when calculating antibiotic use rates. It concludes by discussing opportunities to improve hospital antibiotic use data through electronic prescribing and validating data against other sources.
Supply Chain Pilot Results | Zambia | May 2010ColaLife
A pilot project tested two interventions to improve access to essential medicines in Zambia. System B, where health centers placed direct orders to the Medical Stores Limited (MSL), performed significantly better than System A or comparison districts. Stockout rates were dramatically reduced in System B districts. If scaled nationwide, System B could avert over 27,000 child deaths from malaria annually and reduce child mortality from malaria by up to 37%. The Ministry of Health expressed support for nationwide scale-up of System B to improve availability of lifesaving drugs.
Eversheds Food and Drink Seminar - Health Nutrition Labelling Presentation 3r...Eversheds Sutherland
Eversheds Food and Drink Seminar - Health Nutrition Labelling Presentation 3rd October 2013 - Katharine Vickery, Eversheds LLP.
Current Developments - What’s changed over the past 12 months?
• Nutrition and Health Claims: register of approved claims
What's changed available and informal guidance available;
• New regulation on Generic Descriptors under Article 1(4);
• Judgment on Article 13.5 claims;
• Front of Pack Labeling Scheme introduced; and
• ECJ gives second ruling on meaning of Nutrition and Health Claims Regulation.
Streamlining the clinical trials management process in Spain could attract more international clinical trials to the country, providing economic benefits. Calculations estimated that streamlining activation procedures could increase the number of international clinical trials in Spain by 8% annually, attracting over 137 new trials in 3 years. This could generate 140 million euros in economic impact and create 452 new jobs, while also providing 8,000 patients early access to innovative treatments. Improving management processes could provide Spain a competitive advantage to participate in more global clinical research.
The future of healthcare is an exciting one. With innovations in genomics, healthcare data, advanced therapies and innovative technologies, our industry will continue to progress and provide hope to people so they can live longer, healthier and productive lives.
Mozambique has been working to improve its civil registration and vital statistics (CRVS) system. In 2007, the Ministry of Health started revising the mortality system by implementing an intra-hospital mortality register, training on death certification and ICD-10, and expanding to more sites. This triggered broader inter-sectoral efforts through a working group to expand registration to all deaths and review the entire CRVS system. The working group aims to strengthen death and birth registration and allow easier information sharing between sectors.
The value partnership between NHS, industry and other providersGS1 UK
This document summarizes a presentation given by Dr. Richard Greville on the value partnership between the NHS, pharmaceutical industry, and other healthcare providers in the UK. It discusses several challenges facing the NHS, including the important role of medicines, issues with medicines optimization, and the Pharmaceutical Price Regulation Scheme (PPRS). It outlines efforts through the PPRS and a medicines optimization program between NHS England and the industry group ABPI to improve patient outcomes and extract more value from healthcare spending. Specific initiatives discussed include implementing safety features like serialization and tamper evidence on medicines to protect the supply chain.
The document discusses antibiotic consumption data in UK hospitals. It notes that hospital inpatient antibiotic use increased 11.9% from 2010-2013 while other settings remained stable. There is significant regional variation in antibiotic use both within general practices and between hospitals. The document also examines different methods of dispensing antibiotics in hospitals and issues with using patient days vs. admissions as denominators when calculating antibiotic use rates. It concludes by discussing opportunities to improve hospital antibiotic use data through electronic prescribing and validating data against other sources.
Supply Chain Pilot Results | Zambia | May 2010ColaLife
A pilot project tested two interventions to improve access to essential medicines in Zambia. System B, where health centers placed direct orders to the Medical Stores Limited (MSL), performed significantly better than System A or comparison districts. Stockout rates were dramatically reduced in System B districts. If scaled nationwide, System B could avert over 27,000 child deaths from malaria annually and reduce child mortality from malaria by up to 37%. The Ministry of Health expressed support for nationwide scale-up of System B to improve availability of lifesaving drugs.
Eversheds Food and Drink Seminar - Health Nutrition Labelling Presentation 3r...Eversheds Sutherland
Eversheds Food and Drink Seminar - Health Nutrition Labelling Presentation 3rd October 2013 - Katharine Vickery, Eversheds LLP.
Current Developments - What’s changed over the past 12 months?
• Nutrition and Health Claims: register of approved claims
What's changed available and informal guidance available;
• New regulation on Generic Descriptors under Article 1(4);
• Judgment on Article 13.5 claims;
• Front of Pack Labeling Scheme introduced; and
• ECJ gives second ruling on meaning of Nutrition and Health Claims Regulation.
GS1 UK Healthcare Conference - Masterclass Presentation - Rob DragGS1 UK
This document discusses improving the purchase-to-pay (P2P) process in healthcare organizations. It notes that implementing standards like barcodes, a master data set, and electronic invoices can increase efficiency in the P2P cycle from sourcing to inventory management. However, technology alone is not enough - the process also needs to consider people, updated policies, communication, and data quality. Following standards fully and understanding where current processes have issues are keys to realizing benefits like enhanced spend analytics, increased visibility, traceability from manufacturer to patient, and freeing up clinical time. The main takeaways are to start by understanding current processes, plan for sustainable long-term changes, and recognize that systems and standards only form part of
Medical Device Tracking Symposium SeriesDaren Mooney
A comprehensive educational program by way of webinar-based and interactive sessions providing important background, education and expert-moderated panel discussions of topics relevant to UDI compliance, best-practice and future trends.
The £100bn customer; doing business with the NHSENGAGE_Events
Do you want to engage with one of the UK’s biggest organisations? Not sure where to start? These slides are from our free event in partnership with Wessex Academic Health Science Network that delved into the intricacies of working with the NHS. To find more events like this, visit www.science-park.co.uk/events
White Plains Youth Bureau’s After School Connection ProgramMadhu Kumar
A graduate of the Massachusetts Institute of Technology, Madhu Kumar most recently served as a scientific advisor for Wilson Sonsini Goodrich & Rosati, where he drafted and prosecuted patent applications in the pharmaceutical and life sciences industries. Madhu Kumar has also tutored children and youths through the White Plains Youth Bureau.
This document announces an event taking place from September 12-14, 2016 in Berlin, Germany on overcoming silo structures in regulatory operations and reshaping regulatory information management with IDMP. The event will feature presentations from experts in regulatory operations and information management from various pharmaceutical companies including AstraZeneca, Janssen Pharmaceutical, Novo Nordisk, LEO Pharma, Meda Pharma, and Boehringer Ingelheim. Attendees will learn about regulatory excellence, becoming ready for IDMP and regulatory information management standards from these industry leaders.
Leveraging UDI Database Requirements to Drive Data GovernancePTC
Delivered at the event “UDIs and Traceability for Medical Devices 2014” in Munich, May 21 – 22, 2014, Europe's only UDI-dedicated event for the medical device industry – with keynotes from the FDA and European Commission– this slideshare presents a Solution Provider’s perspective on the impact of Master Data on the UDI submission to the FDA UDI data base. In detail, the presentation highlights the following subjects:
- A checklist for compliance – What to consider when selecting a solution for UDI data submission
- Data management as a lever for streamlined submissions – Current situation, challenges, and best practices for establishing data governance within an organization
- How PTC solutions support UDI and data governance – PTC’s UDI solution and the broader approach for central product data management
Free webinar on Unique Device Identificationnykathlen
The document discusses planning and implementation of Unique Device Identification (UDI) requirements within the medical device industry. It outlines a six step process: 1) Developing a UDI compliance plan, 2) Understanding machine readable technology, 3) Managing change, 4) Conducting risk assessments, 5) Implementing UDI across the value chain, and 6) Identifying data sources for FDA reporting. It also provides an overview of compliance dates for UDI labeling and data submission requirements based on device class.
Step-by-Step Approach of Unique Device Identification (UDI)VISAMED GmbH
This document outlines the step-by-step approach for implementing Unique Device Identification (UDI) as required by the FDA. It discusses the history and objectives of UDI, what constitutes a UDI, how UDI benefits patient safety and supply chain efficiency, and the challenges involved in assigning UDIs, modifying packaging and labels, submitting UDI data to the Global UDI Database, and ensuring ongoing compliance. A high-level task list is provided to guide planning and execution of a company's UDI implementation project.
How to Make Postmarket Surveillance More Cost EffectiveApril Bright
When it comes to postmarket surveillance (PMS), it’s common for the costs to outweigh the value. But, by working with the right team, you’ll be able to execute a study that maximizes return on investment and minimizes the financial impact of conducting further observational research. Postmarket study challenges that must be addressed include enrollment delays, patient attrition, long-term follow-up, resourcing demands and global payor requirements. This session will provide a case study of one orthopaedic company’s seamless transition between postmarket approval and post-approval studies.
Europe CE Marking for medical devices under new MDREMERGO
Starting in early 2020, medical devices seeking CE Marking certification in Europe must comply with the new Medical Device Regulation (MDR). This will require appointing personnel responsible for regulatory compliance, classifying the device, appointing an Authorized Representative located in the EU, including labeling with this information, and obtaining a Single Registration Number. Manufacturers must also prepare technical documentation, implement a quality management system, and undergo annual audits by a Notified Body to maintain certification.
As UDI deadlines roll out, OEMs are left with many questions on implementation and compliance, including:
How does FDA recommend we direct mark screws and small implants?
How should we proceed as we await the guidance on the Convenience Kit exemption?
What are best practices for entering submissions to GUDID?
How is FDA enforcing UDI?
FDA officials will speak on UDI adoption and UDI data quality. Bring your questions. Ample time will be saved for Q&A.
Unique Device Identification A Manufacturers ViewGS1 Nederland
This document discusses the challenges medical device manufacturers will face in implementing Unique Device Identification (UDI). It argues that a step-wise implementation timeline is needed as UDI regulations will require adding variable data to automatic identification and data capture (AIDC) markings on individual medical device packages and products. This will be technically challenging due to limited space for small AIDC carriers, requirements to print variable data inline during high-speed packaging, and ensuring the quality and scannability of AIDC markings on different packaging materials. The document advocates for reviewing results between implementation steps to adjust systems as needed before expanding UDI to additional device classes.
The document discusses improving clinical quality in orthopaedic care within the NHS in England. It notes significant increases in joint replacement procedures and revisions in recent years. There is huge variation between trusts in outcomes like infection rates, readmission rates, and litigation costs. The GIRFT program aims to address this variation by collecting comprehensive data on trusts, identifying best practices, and supporting implementation of quality improvements to achieve better outcomes and cost savings. The document advocates for more centralized specialty services and clinical networks to improve quality and training.
Clare Duggan: Challenges and Opportunities for HealthsampopperVSNW
The document discusses challenges and opportunities for the NHS in England. It notes challenges like a £22 billion funding gap, difficulties meeting clinical quality standards, A&E waiting times, and provider quality ratings. Opportunities include stronger collaboration between partners, reducing unwarranted variation, and initiatives like new care models, pathology transformation, and the GP Forward View. Sustainability and Transformation Plans and focusing on nine priority areas are seen as critical to successfully addressing challenges and capitalizing on opportunities.
The document discusses the NHS in England. It provides an overview of the NHS, including that it was launched in 1948 and now serves over 64 million people. It details the large workforce of over 1.6 million. It also discusses NHS funding which comes from taxation and was around £115.4 billion for 2015/16. Private companies have won a significant portion of NHS contracts worth billions, including companies that have donated to the Conservative party. The largest NHS contracts have gone to companies like Virgin Care, Circle Healthcare, and Care UK.
The document discusses how the London Procurement Partnership (LPP) works with NHS organizations in London to manage medicines. It provides an overview of the new NHS landscape and how medicines are managed locally and nationally. It then describes the LPP's pharmacy and medicines workstreams that aim to promote evidence-based, safe, and cost-effective medicine use across primary care, acute/mental health trusts, and cross-sector work. The priorities for these workstreams include procurement, medicines optimization, collaboration, and quality improvement. Dashboards and other tools are used to support stakeholders in improving performance.
NHS Clinical Reference Board and NHS Clinical Evaluation TeamGS1 UK
The document discusses efforts to standardize clinical products and drive savings in the NHS. It notes that the NHS overspend has increased to £2 billion and spends £4.5 billion annually on clinical products. The NHS Clinical Reference Board and Evaluation Team are working to identify areas for standardization and savings across categories like dressings, wound care products, and continence products which could save £58 million and fund over 700 nurses. Case studies show efforts in areas like urinary catheters that reduced infections and saved £111,000 annually. The teams have reviewed specifications for common product categories to develop national standards.
GS1 UK Healthcare Conference - Masterclass Presentation - Rob DragGS1 UK
This document discusses improving the purchase-to-pay (P2P) process in healthcare organizations. It notes that implementing standards like barcodes, a master data set, and electronic invoices can increase efficiency in the P2P cycle from sourcing to inventory management. However, technology alone is not enough - the process also needs to consider people, updated policies, communication, and data quality. Following standards fully and understanding where current processes have issues are keys to realizing benefits like enhanced spend analytics, increased visibility, traceability from manufacturer to patient, and freeing up clinical time. The main takeaways are to start by understanding current processes, plan for sustainable long-term changes, and recognize that systems and standards only form part of
Medical Device Tracking Symposium SeriesDaren Mooney
A comprehensive educational program by way of webinar-based and interactive sessions providing important background, education and expert-moderated panel discussions of topics relevant to UDI compliance, best-practice and future trends.
The £100bn customer; doing business with the NHSENGAGE_Events
Do you want to engage with one of the UK’s biggest organisations? Not sure where to start? These slides are from our free event in partnership with Wessex Academic Health Science Network that delved into the intricacies of working with the NHS. To find more events like this, visit www.science-park.co.uk/events
White Plains Youth Bureau’s After School Connection ProgramMadhu Kumar
A graduate of the Massachusetts Institute of Technology, Madhu Kumar most recently served as a scientific advisor for Wilson Sonsini Goodrich & Rosati, where he drafted and prosecuted patent applications in the pharmaceutical and life sciences industries. Madhu Kumar has also tutored children and youths through the White Plains Youth Bureau.
This document announces an event taking place from September 12-14, 2016 in Berlin, Germany on overcoming silo structures in regulatory operations and reshaping regulatory information management with IDMP. The event will feature presentations from experts in regulatory operations and information management from various pharmaceutical companies including AstraZeneca, Janssen Pharmaceutical, Novo Nordisk, LEO Pharma, Meda Pharma, and Boehringer Ingelheim. Attendees will learn about regulatory excellence, becoming ready for IDMP and regulatory information management standards from these industry leaders.
Leveraging UDI Database Requirements to Drive Data GovernancePTC
Delivered at the event “UDIs and Traceability for Medical Devices 2014” in Munich, May 21 – 22, 2014, Europe's only UDI-dedicated event for the medical device industry – with keynotes from the FDA and European Commission– this slideshare presents a Solution Provider’s perspective on the impact of Master Data on the UDI submission to the FDA UDI data base. In detail, the presentation highlights the following subjects:
- A checklist for compliance – What to consider when selecting a solution for UDI data submission
- Data management as a lever for streamlined submissions – Current situation, challenges, and best practices for establishing data governance within an organization
- How PTC solutions support UDI and data governance – PTC’s UDI solution and the broader approach for central product data management
Free webinar on Unique Device Identificationnykathlen
The document discusses planning and implementation of Unique Device Identification (UDI) requirements within the medical device industry. It outlines a six step process: 1) Developing a UDI compliance plan, 2) Understanding machine readable technology, 3) Managing change, 4) Conducting risk assessments, 5) Implementing UDI across the value chain, and 6) Identifying data sources for FDA reporting. It also provides an overview of compliance dates for UDI labeling and data submission requirements based on device class.
Step-by-Step Approach of Unique Device Identification (UDI)VISAMED GmbH
This document outlines the step-by-step approach for implementing Unique Device Identification (UDI) as required by the FDA. It discusses the history and objectives of UDI, what constitutes a UDI, how UDI benefits patient safety and supply chain efficiency, and the challenges involved in assigning UDIs, modifying packaging and labels, submitting UDI data to the Global UDI Database, and ensuring ongoing compliance. A high-level task list is provided to guide planning and execution of a company's UDI implementation project.
How to Make Postmarket Surveillance More Cost EffectiveApril Bright
When it comes to postmarket surveillance (PMS), it’s common for the costs to outweigh the value. But, by working with the right team, you’ll be able to execute a study that maximizes return on investment and minimizes the financial impact of conducting further observational research. Postmarket study challenges that must be addressed include enrollment delays, patient attrition, long-term follow-up, resourcing demands and global payor requirements. This session will provide a case study of one orthopaedic company’s seamless transition between postmarket approval and post-approval studies.
Europe CE Marking for medical devices under new MDREMERGO
Starting in early 2020, medical devices seeking CE Marking certification in Europe must comply with the new Medical Device Regulation (MDR). This will require appointing personnel responsible for regulatory compliance, classifying the device, appointing an Authorized Representative located in the EU, including labeling with this information, and obtaining a Single Registration Number. Manufacturers must also prepare technical documentation, implement a quality management system, and undergo annual audits by a Notified Body to maintain certification.
As UDI deadlines roll out, OEMs are left with many questions on implementation and compliance, including:
How does FDA recommend we direct mark screws and small implants?
How should we proceed as we await the guidance on the Convenience Kit exemption?
What are best practices for entering submissions to GUDID?
How is FDA enforcing UDI?
FDA officials will speak on UDI adoption and UDI data quality. Bring your questions. Ample time will be saved for Q&A.
Unique Device Identification A Manufacturers ViewGS1 Nederland
This document discusses the challenges medical device manufacturers will face in implementing Unique Device Identification (UDI). It argues that a step-wise implementation timeline is needed as UDI regulations will require adding variable data to automatic identification and data capture (AIDC) markings on individual medical device packages and products. This will be technically challenging due to limited space for small AIDC carriers, requirements to print variable data inline during high-speed packaging, and ensuring the quality and scannability of AIDC markings on different packaging materials. The document advocates for reviewing results between implementation steps to adjust systems as needed before expanding UDI to additional device classes.
The document discusses improving clinical quality in orthopaedic care within the NHS in England. It notes significant increases in joint replacement procedures and revisions in recent years. There is huge variation between trusts in outcomes like infection rates, readmission rates, and litigation costs. The GIRFT program aims to address this variation by collecting comprehensive data on trusts, identifying best practices, and supporting implementation of quality improvements to achieve better outcomes and cost savings. The document advocates for more centralized specialty services and clinical networks to improve quality and training.
Clare Duggan: Challenges and Opportunities for HealthsampopperVSNW
The document discusses challenges and opportunities for the NHS in England. It notes challenges like a £22 billion funding gap, difficulties meeting clinical quality standards, A&E waiting times, and provider quality ratings. Opportunities include stronger collaboration between partners, reducing unwarranted variation, and initiatives like new care models, pathology transformation, and the GP Forward View. Sustainability and Transformation Plans and focusing on nine priority areas are seen as critical to successfully addressing challenges and capitalizing on opportunities.
The document discusses the NHS in England. It provides an overview of the NHS, including that it was launched in 1948 and now serves over 64 million people. It details the large workforce of over 1.6 million. It also discusses NHS funding which comes from taxation and was around £115.4 billion for 2015/16. Private companies have won a significant portion of NHS contracts worth billions, including companies that have donated to the Conservative party. The largest NHS contracts have gone to companies like Virgin Care, Circle Healthcare, and Care UK.
The document discusses how the London Procurement Partnership (LPP) works with NHS organizations in London to manage medicines. It provides an overview of the new NHS landscape and how medicines are managed locally and nationally. It then describes the LPP's pharmacy and medicines workstreams that aim to promote evidence-based, safe, and cost-effective medicine use across primary care, acute/mental health trusts, and cross-sector work. The priorities for these workstreams include procurement, medicines optimization, collaboration, and quality improvement. Dashboards and other tools are used to support stakeholders in improving performance.
NHS Clinical Reference Board and NHS Clinical Evaluation TeamGS1 UK
The document discusses efforts to standardize clinical products and drive savings in the NHS. It notes that the NHS overspend has increased to £2 billion and spends £4.5 billion annually on clinical products. The NHS Clinical Reference Board and Evaluation Team are working to identify areas for standardization and savings across categories like dressings, wound care products, and continence products which could save £58 million and fund over 700 nurses. Case studies show efforts in areas like urinary catheters that reduced infections and saved £111,000 annually. The teams have reviewed specifications for common product categories to develop national standards.
The document summarizes highlights from the 2017 annual general meeting of the Royal Pharmaceutical Society (RPS). Key points include: securing £2.5 million in funding for clinical diplomas for pharmacists supporting people with long-term conditions; investments to support pharmacists working in care homes and providing urgent medicines supplies; and expanded access to summary care records for pharmacists in England. Highlights are also provided from the RPS boards in England, Scotland, and Wales, including policy work, conferences, and priorities for 2017 on issues like long-term conditions, care homes, and workforce development.
Large scale implementation of electronic transfers of care to pharmacy in Che...Innovation Agency
Presentation by Hassan Argomandkhah, Chair of Pharmacy Local Professional Network NHS England (Merseyside), Innovation Show at Aintree Park Racecourse, 2 May
This slidepack contains figures and charts from analysis that is an update to the April 2015 Health Foundation report, 'Hospital finances and productivity: in critical condition?'
The analysis shows that the productivity of acute hospitals in England has continued to deteriorate. Overall, the productivity of acute hospitals increased by only 0.3% between 2009/10 and 2014/15 – an average rate of 0.1% per year. Between 2009/10 and 2014/15 as a whole, activity growth and input growth have converged leading to the very low level of annual average productivity growth.
The NHS’ vision for medicines optimisation - the role for pharma in driving ...PM Society
The document discusses the challenges facing the NHS, including an aging population and rising costs of medicines. It notes that 30-50% of medicines are not taken as intended, leading to poor patient outcomes and increased healthcare spending. The NHS envisions a strategy of "medicines optimisation" to improve adherence, safety, and value. This will require engaging patients, health professionals, companies, and using health technology to optimize the use and management of medicines across care settings.
The Great Britain health system is publicly funded through general taxation and administered through the National Health Service (NHS). Key facts about the system include: it provides universal coverage to all citizens and residents; spending accounts for 9.6% of GDP; and services include preventative, inpatient, outpatient, dental and mental healthcare free at the point of use. The system faces challenges of rising costs and demand, quality variations, and wait times for elective procedures.
This document discusses the issues with the current UK prescription charging system and examines the potential impacts of abolishing charges. It notes that prescription volumes and costs have risen significantly in recent decades. The current exemptions are viewed as unfair and illogical. Evidence shows that charges deter essential medication use by those with long-term conditions. Abolishing charges could improve health outcomes and save costs elsewhere in the healthcare system. The experiences of Scotland and Wales in gradually eliminating charges are examined.
Financial pressures on the NHS are continuing to mount, with experts predicting a worrying £2 billion deficit in the NHS budget in 2015/16. With the supply of funding struggling to match growing demand, the NHS finds itself facing an unprecedented financial challenge.
This infographic pulls together the latest facts and figures on NHS finances and the pressures on its purse, painting a picture of a service at boiling point. The NHS Confederation is calling for a commitment from politicians for a ten-year spending settlement on the NHS to give members the space to release the pressure.
Our series of organograms explain how the NHS is now structured, including how providers are regulated, who can influence the commissioning of services and where the money goes.
The importance of GS1 standards in delivering efficiency and productivity pro...GS1 UK
This document discusses how adopting GS1 standards could improve efficiency and productivity in the NHS. It notes that the NHS performs well internationally but still faces challenges operating as a 1940s system in the modern world. Adopting GS1 standards could help standardize processes, reduce clinical variation, improve procurement practices, and free up clinicians' time by reducing administrative burdens. Several NHS trusts are acting as demonstrator sites to test how GS1 standards can generate savings and clinical benefits. Overall adoption of GS1 standards has the potential to improve patient safety, lower costs, and enhance clinical productivity across the NHS.
The document outlines the challenges facing general practice in the UK, including increased workload, an aging population with more complex needs, and declining GP morale. It then summarizes the General Practice Forward View, which includes £2.4 billion in additional annual funding by 2020-21, expanding the primary care workforce by 5,000 doctors and 5,000 other staff, reducing practice burdens, improving technology and infrastructure, and redesigning care. The key actions focus on accelerating funding, expanding and supporting staffing, reducing burdens, improving the estate and technology, and providing improvement support to practices.
- The document discusses the history and reforms of the British National Health Service (NHS) over several decades under both Conservative and Labour governments. It describes the founding principles of the NHS and the initial problems it faced.
- Major reforms were introduced in the late 20th century to address rising costs and waiting times, including introducing internal markets, increasing the role of private providers, and giving patients more choice.
- From 1997 onward, large investments were made alongside further reforms to liberalize supply and empower demand, such as expanding the independent sector, setting national standards, and increasing patient information and choice. However, health spending decisions remained controversial.
The document summarizes healthcare systems in the United Kingdom and Germany. It discusses funding models for prescription drugs in England, including Clinical Commissioning Groups (CCGs) and the National Institute for Health and Care Excellence (NICE). It also describes the Cancer Drugs Fund in England and reforms to drug pricing in Germany under the AMNOG process.
Better value in the NHS - innovate stage, 3.30pm, 2 september 2015NHS England
Expo is the most significant annual health and social care event in the calendar, uniting more NHS and care leaders, commissioners, clinicians, voluntary sector partners, innovators and media than any other health and care event.
Expo 15 returned to Manchester and was hosted once again by NHS England. Around 5000 people a day from health and care, the voluntary sector, local government, and industry joined together at Manchester Central Convention Centre for two packed days of speakers, workshops, exhibitions and professional development.
This year, Expo was more relevant and engaging than ever before, happening within the first 100 days of the new Government, and almost 12 months after the publication of the NHS Five Year Forward View. It was also a great opportunity to check on and learn from the progress of Greater Manchester as the area prepares to take over a £6 billion devolved health and social care budget, pledging to integrate hospital, community, primary and social care and vastly improve health and well-being.
More information is available online: www.expo.nhs.uk
This document summarizes a meeting to discuss opportunities for Finnish healthcare companies in the UK National Health Service (NHS). The agenda includes presentations on the current NHS landscape, business opportunities and needs, and how Team Finland can support Finnish companies targeting the NHS. The goal is to increase Finnish exports and foreign investment in Finland's healthcare sector by capitalizing on the NHS's need for new solutions and innovations to address budget pressures. Team Finland, which includes organizations like Tekes and Finpro, aims to create a strategy to help Finnish companies succeed in the UK market.
Similar to Royal Cornwall’s implementation plan: A Chief Pharmacist’s perspective (20)
GS1 standards improving clinical effectiveness and patient safetyGS1 UK
1) GS1 standards aim to improve clinical effectiveness and patient safety at Derby Teaching Hospitals NHS Foundation Trust through increased traceability, tracking, and data capture using barcodes.
2) Implementing GS1 standards allows for improved tracking of patients, staff, medical devices, stock consumption, and more. This enhances traceability for product recalls, prevents expired stock wastage, and attributes costs.
3) The presentation provides examples of how GS1 standards have increased efficiency, reduced costs and clinical variation, and improved coding and revenue at the Trust.
Implementing GS1 standards in theatres: Improving patient outcomes, efficienc...GS1 UK
The document discusses how Derby Teaching Hospitals NHS Foundation Trust implemented GS1 standards in their operating theatres to improve patient outcomes, efficiency, and achieve financial benefits. Some key results of implementing GS1 standards included improved tracking of patients, staff, medical devices and consumables; automated replenishment of supplies; reduced stock levels and waste; and increased coding accuracy leading to additional income. Overall the trust estimated savings of around £300,000 per year from business process efficiencies achieved after implementing GS1 standards in theatres. The presentation promotes the use of GS1 standards to enhance patient safety and increase efficiencies across the healthcare supply chain.
Lorna Wilkinson, Director of Nursing at Salisbury NHS Foundation Trust, discusses the trust's journey implementing Scan4Safety. The trust was selected as one of six demonstrator sites for the program. Scan4Safety aims to improve operational efficiency by reducing time spent locating supplies, improve stock management, and automatically replenish stock. It also aims to enhance patient safety by enabling safe product recalls and positive patient identification, reducing medication errors. Scan4Safety is expected to allow clinical staff to spend more time focusing on patient care by streamlining supply processes. The trust is taking a bottom-up collaborative approach to identify how barcoding can add the most value while building internal capability for a sustainable implementation.
Our implementation plan - what GS1 standards mean to me, my hospital and our ...GS1 UK
Nick Thomas, Deputy Chief Executive of Plymouth Hospitals NHS Trust, outlines their implementation plan for GS1 standards. The Trust provides secondary and tertiary care for 1.2 million people across southwest England. It aims to improve quality, access, efficiency and reduce costs and waste using GS1 standards. The goals are to complete GLN and wristband implementation by the third quarter of 2016 and apply GTIN standards to top medical and surgical suppliers and pharmaceuticals. GS1 standards will help improve patient safety, experience and share best practices while providing the right care at the right time.
Alignment with GS1 implementation – A Medtech Industry ViewGS1 UK
Nishan Sunthares, Chief Operating Officer of ABHI, discusses alignment with GS1 implementation from the perspective of the medical technology industry. ABHI champions safe and effective medical technologies to support high quality patient outcomes. While the industry recognizes the value of GS1 implementation in improving efficiencies, safety, and compliance, challenges remain regarding timelines, technical complexity, guidance, and coordinated implementation with the NHS. ABHI will focus on providing members with more information and engaging further with the DH and NHS to gain clarity on requirements and the demonstrator sites. The next steps emphasize continued collaboration between members, partners, and the DH/NHS.
Background to the Falsified Medicines Directive and the Delegated RegulationGS1 UK
The document discusses the Falsified Medicines Directive and Delegated Regulation, which aim to secure the pharmaceutical supply chain and reduce counterfeit medicines. It outlines key aspects of the new regulations, including unique identifiers and tamper-evident packaging for prescription medicines. Verification of authenticity will occur at wholesale distributors and dispensing points. National repositories will store product information to enable verification. Implementation poses scale and connectivity challenges across the complex supply chain. Wider benefits may include improved patient safety, monitoring, and reducing fraud. Flexibilities allow country-specific requirements and earlier verification in some settings like hospitals.
Just do it! - The sustainability of GS1 standardsGS1 UK
This document summarizes Lee Outhwaite's presentation on the sustainability of GS1 standards. The key points are:
1. Outhwaite discussed how GS1 standards can help the NHS achieve its goals for sustainability and transformation plans, improve access to care, maintain quality, and achieve financial balance.
2. Benefits of GS1 standards were highlighted, including increased patient safety by reducing errors, improved regulatory compliance, and greater financial control through efficient supply chain management.
3. Overcoming barriers to implementation was addressed, emphasizing the economic and safety benefits of GS1 standards and support available from various partners like NHS Improvement and suppliers.
This document summarizes a speech given by Professor Terence Stephenson on using GS1 standards to improve patient safety in the NHS. It notes that adverse healthcare events are a leading cause of death in the UK, costing over £1 billion per year. It discusses problems with correctly identifying patients and medical devices. It recommends giving all implanted medical devices a Unique Device Identifier linked to a patient's NHS number to facilitate reporting of device incidents. The speech frames the GMC's role in maintaining a register of doctors, ensuring doctors are qualified, monitoring ongoing fitness to practice, and providing guidance to support safe medical practice as key to modern patient safety efforts.
GS1 UK Healthcare Conference - Masterclass Presentation - Rod BeardGS1 UK
This document describes the integrated electronic prescribing and robotic pharmacy dispensing system at Sunderland Royal Hospital in England. Key points:
- The hospital uses a fully integrated electronic prescribing system linked to a robotic dispensing system. This allows prescriptions to be automatically dispensed and labeled with no risk of errors.
- Integration is critical to realizing the benefits of improved safety, efficiency and speed. With full integration dispensing is nearly instantaneous.
- Studies found the integrated system resulted in zero dispensing errors compared to typical error rates of around 20-25% for conventional dispensing. It also improved turnaround times and pharmacist productivity.
GS1 UK Healthcare Conference - Masterclass Presentation - Bhulesh VadherGS1 UK
This document discusses the Falsified Medicines Directive (FMD) and its implications for hospital pharmacy from a UK perspective. It notes that an estimated 1-10% of medicines globally are counterfeit and the FMD aims to solve this problem through serialization and authentication of medicine packages. A hospital pharmacy pilot found that authentication was possible at various stages with a detection rate of 100% and authentication rates of 60-70%. Staff adapted well to the new system. The FMD will require enormous changes to hospital pharmacy practice but also presents opportunities to improve safety and efficiency.
GS1 UK Healthcare Conference - Masterclass Presentation - Chris Slater and Gr...GS1 UK
Scan4Safety - Demonstrator Site: a view from inside
Chris Slater, Head of Supplies & Procurement & Graham Medwell, eBusinessManager, Leeds Teaching Hospitals NHS Trust
GS1 UK Healthcare Conference 2016 infographicGS1 UK
Join us and learn how GS1 standards are helping the NHS save thousands of lives and millions of pounds. 12 and 13 April 2016, Radisson Blu Edwardian, Heathrow.
https://www.gs1uk.org/healthcare-conference
At Apollo Hospital, Lucknow, U.P., we provide specialized care for children experiencing dehydration and other symptoms. We also offer NICU & PICU Ambulance Facility Services. Consult our expert today for the best pediatric emergency care.
For More Details:
Map: https://cutt.ly/BwCeflYo
Name: Apollo Hospital
Address: Singar Nagar, LDA Colony, Lucknow, Uttar Pradesh 226012
Phone: 08429021957
Opening Hours: 24X7
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...rightmanforbloodline
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
This particular slides consist of- what is hypotension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is the summary of hypotension:
Hypotension, or low blood pressure, is when the pressure of blood circulating in the body is lower than normal or expected. It's only a problem if it negatively impacts the body and causes symptoms. Normal blood pressure is usually between 90/60 mmHg and 120/80 mmHg, but pressures below 90/60 are generally considered hypotensive.
Unlocking the Secrets to Safe Patient Handling.pdfLift Ability
Furthermore, the time constraints and workload in healthcare settings can make it challenging for caregivers to prioritise safe patient handling Australia practices, leading to shortcuts and increased risks.
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDr Rachana Gujar
Introduction: Substance use education is crucial due to its prevalence and societal impact.
Alcohol Use: Immediate and long-term risks include impaired judgment, health issues, and social consequences.
Tobacco Use: Immediate effects include increased heart rate, while long-term risks encompass cancer and heart disease.
Drug Use: Risks vary depending on the drug type, including health and psychological implications.
Prevention Strategies: Education, healthy coping mechanisms, community support, and policies are vital in preventing substance use.
Harm Reduction Strategies: Safe use practices, medication-assisted treatment, and naloxone availability aim to reduce harm.
Seeking Help for Addiction: Recognizing signs, available treatments, support systems, and resources are essential for recovery.
Personal Stories: Real stories of recovery emphasize hope and resilience.
Interactive Q&A: Engage the audience and encourage discussion.
Conclusion: Recap key points and emphasize the importance of awareness, prevention, and seeking help.
Resources: Provide contact information and links for further support.
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
The facial nerve, also known as cranial nerve VII, is one of the 12 cranial nerves originating from the brain. It's a mixed nerve, meaning it contains both sensory and motor fibres, and it plays a crucial role in controlling various facial muscles, as well as conveying sensory information from the taste buds on the anterior two-thirds of the tongue.
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
MBC Support Group for Black Women – Insights in Genetic Testing.pdfbkling
Christina Spears, breast cancer genetic counselor at the Ohio State University Comprehensive Cancer Center, joined us for the MBC Support Group for Black Women to discuss the importance of genetic testing in communities of color and answer pressing questions.
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
Common Challenges in Dermatology Billing and How to Overcome.pptx
Royal Cornwall’s implementation plan: A Chief Pharmacist’s perspective
1. Iain Davidson, Chief Clinical Information Officer and Chief Pharmacist, Royal Cornwall Hospitals NHS Trust
Royal Cornwall’s implementation plan:
A Chief Pharmacist’s perspective
13 April 2016